We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The new drug will be available for sale as early as September, with the company planning to conduct clinical tests in the United States at the end of the year.